z-logo
Premium
Role of standardized grape polyphenol preparation as a novel treatment to improve synaptic plasticity through attenuation of features of metabolic syndrome in a mouse model
Author(s) -
Wang Jun,
Tang Cheuk,
Ferruzzi Mario G.,
Gong Bing,
Song Brian J.,
Janle Elsa M.,
Chen TzuYing,
Cooper Bruce,
Varghese Merina,
Cheng Alice,
Freire Daniel,
Bilski Amanda,
Roman Jessica,
Nguyen Tuyen,
Ho Lap,
Talcott Stephen T.,
Simon James E.,
Wu Qingli,
Pasinetti Giulio M.
Publication year - 2013
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201300230
Subject(s) - resveratrol , synaptic plasticity , polyphenol , metabolic syndrome , neuroscience , biology , neuroplasticity , medicine , pharmacology , obesity , biochemistry , endocrinology , receptor , antioxidant
Scope Metabolic syndrome has become an epidemic and poses tremendous burden on the health system. People with metabolic syndrome are more likely to experience cognitive decline. As obesity and sedentary lifestyles become more common, the development of early prevention strategies is critical. In this study, we explore the potential beneficial effects of a combinatory polyphenol preparation composed of grape seed extract, Concord purple grape juice extract, and resveratrol, referred to as standardized grape polyphenol preparation (SGP), on peripheral as well as brain dysfunction induced by metabolic syndrome. Methods and results We found dietary fat content had minimal effect on absorption of metabolites of major polyphenols derived from SGP. Using a diet‐induced animal model of metabolic syndrome (DIM), we found that brain functional connectivity and synaptic plasticity are compromised in the DIM mice. Treatment with SGP not only prevented peripheral metabolic abnormality but also improved brain synaptic plasticity. Conclusion Our study demonstrated that SGP, comprised of multiple bioavailable and bioactive components targeting a wide range of metabolic syndrome related pathological features, provides greater global protection against peripheral and central nervous system dysfunctions and can be potentially developed as a novel prevention/treatment for improving brain connectivity and synaptic plasticity important for learning and memory.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here